Database Update: Pharmaceutical Drug Import to Russia (May 2017)
Between January and May 2017, Russia imported 194.5 bln RUB worth of ready-made drugs (free circulation prices), which is 10.5% higher than that of the same period of 2016. Despite the progress made at the beginning of the year, the import increased by 9.6% in May against nearly 16% in April. As for the in-bulk import, the dynamics were as low as -24.7% in monetary terms, with 35.5 bln RUB.
In physical terms, the import of ready-made drugs is growing. Between January and May, Russia imported 789.7 mln units, which is 7.1% higher than that of the same period of 2016. However, the increase was 15.7% in May and only 6.6% in April. The numbers are due to the growing demand for units with fewer single doses. If calculated in minimum dosage units (MDU), the dynamics are -4.3%. Despite the decrease in monetary terms, the in-bulk import has increased by 8.3% if calculated in MDU.
The number of payments in rubles is still growing, with 95% of all the imported drugs having been payed for in rubles between January and May 2017. The number of payments currencies is growing, too, in particular, Russia started to pay in yenas and yuans for Japanese and Chinese imports in 2017. Japan exported Catalin (Senju Pharmaceutical), while China exported Misoprostolum (China Resources Zizhu.)
Read more about pharmaceutical drug import to Russia (April performance) here: http://rncph.com/news/19_05_2017
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2016 – May 2017)